October 25, 2015 Breath temperature test may help diagnose lung cancer Doctors may be able to diagnose lung cancer by gauging the temperature of exhaled breath.
October 25, 2015 Pfizer drug effective in patients with rare lung cancer, study shows Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday.
October 25, 2015 Novartis reports lung cancer patients respond to drug in study Novartis said late on Wednesday that a majority of patients given a development drug against non-small cell lung cancer had responded to the treatment, according to study results published in the New England Journal of Medicine.
October 25, 2015 California scientists test Ecstasy as anxiety-reducer for gravely ill California scientists are testing whether the illegal psychoactive drug commonly known as Ecstasy could help alleviate anxiety for terminally ill patients, the trial's principal funder said on Tuesday.
October 24, 2015 Smoking causes 14 million medical conditions in US yearly, study finds Smoking is to blame for about 14 million major medical conditions among American adults yearly, a new study shows.
October 24, 2015 Koch, Kravis donate total of $250M for hospitals, research Industrialist David H. Koch (kohk) and financier Henry R. Kravis have made separate donations totaling $250 million for hospitals and medical research in New York City.
October 24, 2015 Heart group says e-cigarettes might help smokers quit The American Heart Association's first policy statement on electronic cigarettes backs them as a last resort to help smokers quit. The American Cancer Society has no formal policy but quietly took a similar stance in May.
October 24, 2015 11 California schools closed for asbestos testing School officials in California closed 11 Orange County schools to test the properties for cancer-causing asbestos, MyFoxLA.com reported.
October 24, 2015 FDA expands lung cancer approval for Bristol-Myers' drug The U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co's immunotherapy drug Opdivo for patients with an additional form of advanced lung cancer.
October 24, 2015 FDA approves Bristol Myers Squibb’s Opdivo for lung cancer U.S. regulators approved Bristol-Myers Squibb Co. ’s advanced lung cancer drug Opdivo, the latest of a string of events that has focused efforts on using the immune system to battle the disease.
